Medicines and Healthcare products Regulatory Agency
MHRA issues drug alert after drugs mislabelled
Pharmacists have been warned to be aware of possible wrong labelling on a number of batches of drugs including medicines to treat epilepsy, anxiety and depression.
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert for a number of products produced by Focus Pharmaceuticals warning that an error with barcodes has been discovered on some batches.
It said that when the barcodes are scanned, they may not identify the product. The other product details printed on the carton, including the name, strength and pharmaceutical form of the medicine are correct.
The drugs affected include pregabalin oral solution, trazodone capsules, nortriptyline tablets, nefopam hydrochloride tablets, and dicycloverine tablets and oral solution.
The MHRA has asked any pharmacy that holds this stock to remove it from robotic or automated dispensing systems, and carry out manual dispensing using the written labelling instead.
The MHRA said that there was no risk to the quality of the product from the incorrect barcoding, so the affected batches are not being recalled by the manufacturer.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203523
Recommended from Pharmaceutical Press
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£80.00Buy now
Pharmaceutics: Drug Delivery and Targeting systematically reviews important concepts for drug delivery systems and targeting of drugs.£24.00Buy now
All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.£52.00Buy now